Država: Španjolska
Jezik: engleski
Izvor: HMA (Heads of Medicines Agencies)
mannheimia haemolytica (pasteurella) 68 ELISA.U
Merial
QI02AB04
Suspension for injection
Pasteurella
Cattle
2012-01-25
June 2007 Page 1 of 31 _ _ SUMMARY OF PRODUCT CHARACTERISTICS June 2007 Page 2 of 31 1. NAME OF THE VETERINARY MEDICINAL PRODUCT PASTOBOV 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: _Mannheimia haemolytica*_ type A1 antigen: leucotoxin minimum of............................68 ELISA.U** * _Mannheimia haemolytica_ was formerly called _Pasteurella haemolytica_ ** 1 ELISA.U: q.s. to obtain a _Mannheimia haemolytica_ antibody titre of 1 ELISA unit in mice after two administrations of vaccine ADJUVANT(S): Aluminium (as hydroxide) ...................................................................................................... 4.2 mg EXCIPIENT(S): Thiomersal............................................................................................................................ 0.2 mg Excipient ......................................................................................................... q.s.p. 1 dose of 2 ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection – Milky beige 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunisation of cattle to reduce clinical signs and lesions of _Mannheimia haemolytica_* A1 induced respiratory disease. 4.3 CONTRAINDICATIONS None 4.4 SPECIAL WARNINGS None 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Shake well before use. Apply usual aseptic procedures Vaccinate only healthy animals Apply usual procedures for the handling of the animals. 3 of 31 SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Pročitajte cijeli dokument